# FDA recall D-844-2013

> **Novartis Consumer Health** · Class II · drug recall initiated 2013-06-06.

## Product

Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouches, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 203 702     Foreign packaging: b) Excedrin Migrana (Acetaminophen 250 mg, Aspirin 250 mg and 65 mg Caffeine) 2-ct pouches.  The foreign packaging do not have NDC numbers

## Reason for recall

Defective container: products are packaged in pouches which may not have been fully sealed

## Distribution

Nationwide, Puerto Rico, Brazil and Panama

## Key facts

- **Recall number:** D-844-2013
- **Recalling firm:** Novartis Consumer Health
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-06-06
- **Report date:** 2013-08-14
- **Termination date:** 2014-11-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lincoln, NE, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-844-2013

## Citation

> AI Analytics. FDA recall D-844-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-844-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*